PAA is the only Oncology company to have carried out a Phase II Human Trial and have a MC under $100m.
Regulatory Permission was given back in 2016 to reformulate and carry out a Phase IIb Human Trial .... reformulation has been on the agenda for 5 years now.
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=366350 PAA Human Cancer Trial Link.
. Sufficient data was obtained to permit proceeding to Phase II study, i.e. a safe and active dose. The study was also terminated to permit reformulation of study drug to a more palatable formulation
Quarterly will be out in 10 days... I hope PAA aren't saving news for that....
Maybe an idea to have the CEO in the same Hemisphere as the company??
Covi-Pantel . NZ Trader Release, page-1422
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.005(2.86%) |
Mkt cap ! $87.51M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.3¢ | 17.5¢ | $205.5K | 1.150M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 55777 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 56756 | 2 |
View Market Depth
| Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |